Found: 101
Select item for more details and to access through your institution.
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01081-z
- By:
- Publication type:
- Article
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00900-z
- By:
- Publication type:
- Article
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 2, p. 239, doi. 10.1111/bjh.18357
- By:
- Publication type:
- Article
Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 95, doi. 10.1111/bjh.18298
- By:
- Publication type:
- Article
Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 380, doi. 10.1111/bjh.17195
- By:
- Publication type:
- Article
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 3, p. 394, doi. 10.1111/bjh.16168
- By:
- Publication type:
- Article
Ten‐year survivors in AL amyloidosis: characteristics and treatment pattern.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 588, doi. 10.1111/bjh.16096
- By:
- Publication type:
- Article
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 3, p. 421, doi. 10.1111/bjh.15545
- By:
- Publication type:
- Article
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 1, p. 71, doi. 10.1111/bjh.15244
- By:
- Publication type:
- Article
Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 888, doi. 10.1111/bjh.14830
- By:
- Publication type:
- Article
Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 89, doi. 10.1111/bjh.13799
- By:
- Publication type:
- Article
Long‐term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 11, p. 2118, doi. 10.1002/ajh.27460
- By:
- Publication type:
- Article
Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E318, doi. 10.1002/ajh.27060
- By:
- Publication type:
- Article
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
- By:
- Publication type:
- Article
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. E255, doi. 10.1002/ajh.27019
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 401, doi. 10.1002/ajh.26466
- By:
- Publication type:
- Article
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 209, doi. 10.1002/ajh.26422
- By:
- Publication type:
- Article
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 90, doi. 10.1002/ajh.26388
- By:
- Publication type:
- Article
Prognostic significance of acquired 1q22 gain in multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 52, doi. 10.1002/ajh.26391
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
- By:
- Publication type:
- Article
The prognostic significance of del6q23 in chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. E203, doi. 10.1002/ajh.26168
- By:
- Publication type:
- Article
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 446, doi. 10.1002/ajh.26092
- By:
- Publication type:
- Article
Novel imaging techniques using <sup>18</sup>F‐florbetapir PET/MRI can guide fascicular nerve biopsy in amyloid multiple mononeuropathy.
- Published in:
- Muscle & Nerve, 2021, v. 63, n. 1, p. 104, doi. 10.1002/mus.27100
- By:
- Publication type:
- Article
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3
- By:
- Publication type:
- Article
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 433, doi. 10.1111/ejh.13559
- By:
- Publication type:
- Article
Characterization and prognostic implication of delayed complete response in AL amyloidosis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 354, doi. 10.1111/ejh.13554
- By:
- Publication type:
- Article
Early Intervention in Asymptomatic Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 2, p. 1
- By:
- Publication type:
- Article
AL amyloidosis clonal plasma cells are regulated by microRNAs and dependent on anti‐apoptotic BCL2 family members.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8199, doi. 10.1002/cam4.5621
- By:
- Publication type:
- Article
Colon perforation in multiple myeloma patients – A complication of high‐dose steroid treatment.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8895, doi. 10.1002/cam4.3507
- By:
- Publication type:
- Article
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 10, p. 3390, doi. 10.1002/cam4.2998
- By:
- Publication type:
- Article
Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 4, p. 187, doi. 10.1177/2040620716652862
- By:
- Publication type:
- Article
A practical review on carfilzomib in multiple myeloma.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 6, p. 564, doi. 10.1111/ejh.12749
- By:
- Publication type:
- Article
Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessment.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 2, p. 136, doi. 10.1111/ejh.12558
- By:
- Publication type:
- Article
Unravelling hypothyroidism in AL amyloidosis: Authors' reply.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. e104, doi. 10.1016/j.clml.2023.11.008
- By:
- Publication type:
- Article
P-140: Monoclonal proteinuria ≥200 mg/24h predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S111, doi. 10.1016/S2152-2650(21)02267-9
- By:
- Publication type:
- Article
OAB-038: Graded cardiac response criteria for AL amyloidosis: the impact of depth of cardiac response on survival.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02112-1
- By:
- Publication type:
- Article
OAB-036: Graded renal response criteria and revised renal progression criteria for light chain (AL) amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S23, doi. 10.1016/S2152-2650(21)02110-8
- By:
- Publication type:
- Article
OAB-037: Assessing the prognostic utility of the Mayo 2018 and IMWG 2020 smoldering multiple myeloma risk stratification scores applied post diagnosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02111-X
- By:
- Publication type:
- Article
MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S435, doi. 10.1016/S2152-2650(21)01970-4
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
CLL-376: Clinical Characteristics and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL), 80 Years of Age or Older.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S324, doi. 10.1016/S2152-2650(21)01762-6
- By:
- Publication type:
- Article
Poster: MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01605-0
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Poster: CLL-376: Clinical Characteristics and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL), 80 Years of Age or Older.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S223, doi. 10.1016/S2152-2650(21)01403-8
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. 451, doi. 10.1016/j.clml.2021.02.001
- By:
- Publication type:
- Article